InvestorsHub Logo
Followers 2
Posts 1472
Boards Moderated 0
Alias Born 07/20/2016

Re: DewDiligence post# 47496

Wednesday, 12/27/2017 10:54:58 AM

Wednesday, December 27, 2017 10:54:58 AM

Post# of 108192
Thank you for that link, Dew. I also found this interesting: "In the study on which Hacohen and Wu collaborated, six people with melanoma received vaccines containing as many as 20 neoantigens each. Four of the patients were cancer-free two and a half years later. The tumours also disappeared in the other two patients, but only after treatment with a checkpoint inhibitor.

The other 2017 study, led by Ugur Sahin at Johannes Gutenberg University of Mainz in Germany, involved 13 people with melanoma, whose vaccines each contained a mix of 10 neoantigens. Nine of these people were cancer-free after a follow-up period of 12–23 months: eight had been given the vaccine alone and the other an additional checkpoint inhibitor."

Emphasis added.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News